or Try an Advanced Search...

    Dystrophy Stocks List

    Symbol Grade Name % Change
    TVTX B Travere Therapeutics, Inc. 2.24
    PTCT B PTC Therapeutics, Inc. 2.22
    ELMD B Electromed, Inc. -3.90
    BMY B Bristol-Myers Squibb Company 0.60
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Disorders Medicine Muscular Dystrophy Rare Diseases Sickle Cell Disease Thalassemia Acromegaly Alcohol Alport Syndrome Amyloid Amyloidosis Angioedema Antisense RNA Apatorsen Biopharmaceutical Biotechnology Cancer Cardiomyopathy Childhood Cholesterol

    Related ETFs - A few ETFs which own one or more of the above listed Dystrophy stocks.

    Symbol Grade Name Weight
    ARKG F ARK Genomic Revolution Multi-Sector ETF 3.85
    MEDX F Horizon Kinetics Medical ETF 2.86
    MNTL D Tema Neuroscience and Mental Health ETF 2.66
    HRTS F Tema Cardiovascular and Metabolic ETF 2.42
    HELX D Franklin Genomic Advancements ETF 2.1
    View all Dystrophy ETFs...
    Compare ETFs
    Compare ARKG to HELX Compare ARKG to MNTL Compare HRTS to HELX

        Dystrophy Stocks Recent News

        Date Stock Title
        Nov 21 BMY Major companies that are also popular short-selling stocks
        Nov 21 BMY Is Bristol Myers Squibb Stock a Buy?
        Nov 21 BMY Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
        Nov 19 BMY Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)
        Nov 19 BMY Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms
        Nov 18 BMY Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
        Nov 18 BMY Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?
        Nov 18 BMY EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer
        Nov 17 BMY Bristol-Myers Squibb: Buy This Bargain Before It's Gone
        Nov 17 BMY Large Pension Doubled Palantir Stake, Bought Up Intel and CVS Stock
        Nov 15 BMY Large pharmas, biotechs down as industries grapple with RFK Jr. at HHS
        Nov 15 TVTX Exploring Three High Growth Tech Stocks in the United States
        Nov 15 BMY Bristol Myers gets positive EMA opinion for repotrectinib
        Nov 15 BMY Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer
        Nov 15 BMY Bristol Myers Squibb Receives Positive CHMP Opinion for Repotrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer and Advanced NTRK-Positive Solid Tumors
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Disorders Medicine Muscular Dystrophy Rare Diseases Sickle Cell Disease Thalassemia Acromegaly Alcohol Alport Syndrome Amyloid Amyloidosis Angioedema Antisense RNA Apatorsen Biopharmaceutical Biotechnology Cancer Cardiomyopathy Childhood Cholesterol
        Dystrophy

        Dystrophy is the degeneration of tissue, due to disease or malnutrition, most likely due to heredity.

        More about Dystrophy
        Browse All Tags